Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Nicola Zerbinati, Sami Ullah Mumtaz et al.|Frontiers in Pharmacology|2023Cited by 54
Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of Clostridium butyricum CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional StudyFrancesco Di Pierro, Nicola Zerbinati, N. Memon et al.|Microorganisms|2025Cited by 8
Effect of orally administered L. crispatus M247 in favoring HR-HPV clearance and CST shift: results from a randomized, multi-center, placebo-controlled trialFrancesco Di Pierro, E Lomeo, Alessia Pivetti et al.|Scientific Reports|2025Cited by 4
Correction: Effect of orally administered L. crispatus M247 in favoring HR-HPV clearance and CST shift: results from a randomized, multi-center, placebo-controlled trialFrancesco Di Pierro, E Lomeo, Alessia Pivetti et al.|Scientific Reports|2025Cited by 0